Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Biotech
Moderna won't advance US-backed Zika vaccine without more money
Moderna will not advance a midstage Zika vaccine without more cash, despite receiving U.S. funding, according to a regulatory disclosure.
Max Bayer
Mar 15, 2024 11:10am
Gritstone lays off 40% of team after delaying COVID vax trial
Feb 29, 2024 4:05pm
A 'live fire exercise' with COVID preps SAB for new (old) focus
Oct 16, 2023 6:00am
ModeX nets up to $168M in BARDA bucks to cook up new antibodies
Sep 29, 2023 10:43am
Gritstone gets $433M in BARDA funds to trial mRNA COVID-19 shot
Sep 28, 2023 5:54am
Regeneron snags $326M from BARDA for next-gen COVID antibody
Aug 23, 2023 7:15am